pentoxifylline has been researched along with Hepato-Pulmonary Syndrome in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effects of pentoxifylline (PTX) on clinical manifestations and evaluate arterial blood gas data in hepatopulmonary syndrome (HPS) in children." | 7.78 | Pentoxifylline in hepatopulmonary syndrome. ( Afzal Aghaei, M; Khalesi, M; Kianifar, HR; Mahmoodi, E, 2012) |
| "Treatment with pentoxifylline did not improve arterial oxygenation in advanced HPS, and tolerance was limited by gastrointestinal toxicity." | 6.73 | Pilot study of pentoxifylline in hepatopulmonary syndrome. ( Fallon, MB; Faulk, DK; Kawut, SM; Philips, GM; Tanikella, R, 2008) |
| "Treatment with pentoxifylline did not improve arterial oxygenation in advanced HPS, and tolerance was limited by gastrointestinal toxicity." | 2.73 | Pilot study of pentoxifylline in hepatopulmonary syndrome. ( Fallon, MB; Faulk, DK; Kawut, SM; Philips, GM; Tanikella, R, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakr, AG | 1 |
| El-Bahrawy, AH | 1 |
| Taha, HH | 1 |
| Ali, FEM | 1 |
| Aljudaibi, B | 1 |
| Qumosani, K | 1 |
| Chandok, N | 1 |
| Tanikella, R | 1 |
| Philips, GM | 1 |
| Faulk, DK | 1 |
| Kawut, SM | 1 |
| Fallon, MB | 3 |
| Gupta, LB | 1 |
| Kumar, A | 1 |
| Jaiswal, AK | 1 |
| Yusuf, J | 1 |
| Mehta, V | 1 |
| Tyagi, S | 1 |
| Tempe, DK | 1 |
| Sharma, BC | 1 |
| Sarin, SK | 1 |
| Zhang, J | 2 |
| Luo, B | 2 |
| Tang, L | 2 |
| Wang, Y | 1 |
| Stockard, CR | 1 |
| Kadish, I | 1 |
| Van Groen, T | 1 |
| Grizzle, WE | 1 |
| Ponnazhagan, S | 1 |
| Kianifar, HR | 1 |
| Khalesi, M | 1 |
| Mahmoodi, E | 1 |
| Afzal Aghaei, M | 1 |
| Dinh-Xuan, AT | 1 |
| Naeije, R | 1 |
| Sztrymf, B | 1 |
| Rabiller, A | 1 |
| Nunes, H | 1 |
| Savale, L | 1 |
| Lebrec, D | 1 |
| Le Pape, A | 1 |
| de Montpreville, V | 1 |
| Mazmanian, M | 1 |
| Humbert, M | 1 |
| Hervé, P | 1 |
| Ling, Y | 1 |
| Chacko, BK | 1 |
| Patel, RP | 1 |
| Pastor, CM | 1 |
| Schiffer, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open Label Single Arm Pilot Study of Pentoxifylline in Advanced Hepatopulmonary Syndrome[NCT00593658] | Phase 1 | 9 participants (Actual) | Interventional | 2004-06-30 | Terminated (stopped due to Poor tolerability of drug and side effects) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for pentoxifylline and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
The hepatopulmonary syndrome: NO way out?
Topics: Enzyme Inhibitors; Hepatopulmonary Syndrome; Humans; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxi | 2004 |
Therapy Insight: hepatopulmonary syndrome and orthotopic liver transplantation.
Topics: Algorithms; Animals; Diagnosis, Differential; Embolization, Therapeutic; Hepatopulmonary Syndrome; H | 2007 |
1 trial available for pentoxifylline and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Pilot study of pentoxifylline in hepatopulmonary syndrome.
Topics: Aged; Blood Gas Analysis; Female; Hepatopulmonary Syndrome; Humans; Liver Cirrhosis; Male; Middle Ag | 2008 |
7 other studies available for pentoxifylline and Hepato-Pulmonary Syndrome
| Article | Year |
|---|---|
Diosmin enhances the anti-angiogenic activity of sildenafil and pentoxifylline against hepatopulmonary syndrome via regulation of TNF-α/VEGF, IGF-1/PI3K/AKT, and FGF-1/ANG-2 signaling pathways.
Topics: Angiogenesis Inhibitors; Angiotensin II; Animals; Diosmin; Drug Synergism; Fibroblast Growth Factor | 2020 |
Pentoxifylline for slow to resolve hepatopulmonary syndrome post liver transplantation: helpful or unnecessary?
Topics: Adult; Combined Modality Therapy; Hepatopulmonary Syndrome; Humans; Liver Transplantation; Male; Mid | 2013 |
Pentoxifylline therapy for hepatopulmonary syndrome: a pilot study.
Topics: Adolescent; Adult; Animals; Blood Gas Analysis; Female; Hepatopulmonary Syndrome; Humans; Male; Midd | 2008 |
Pulmonary angiogenesis in a rat model of hepatopulmonary syndrome.
Topics: Angiostatins; Animals; Common Bile Duct; Disease Models, Animal; Endostatins; Hepatopulmonary Syndro | 2009 |
Pentoxifylline in hepatopulmonary syndrome.
Topics: Adolescent; Blood Gas Analysis; Child; Child, Preschool; Female; Hepatopulmonary Syndrome; Humans; M | 2012 |
Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats.
Topics: Animals; Aorta; Bacterial Translocation; Blood Cells; Blood Circulation; Enzyme Inhibitors; Hemodyna | 2004 |
Pentoxifylline attenuation of experimental hepatopulmonary syndrome.
Topics: Animals; Cells, Cultured; Common Bile Duct; Cyclic AMP; Endothelial Cells; Endothelium, Vascular; He | 2007 |